{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T14:21:07Z","timestamp":1795011667060,"version":"4.9.1"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>We estimated cancer mortality figures for 2026 in five major Asian countries and Australia, with a specific focus on prostate cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We computed country- and sex-specific annual age-standardized mortality rates (ASRs) for all cancers combined and for the 10 most common cancer sites, using data from the WHO and the United Nations Population Division up to 2022 or the most recent available year. We predicted figures for 2026 and estimated the number of avoided cancer deaths in 1994\u20132026.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Predicted mortality rates for all cancers combined in 2026 are favourable across all considered countries and in both sexes, with the largest declines expected in the Republic of Korea (\u221220.5% in males and \u221210.2% in females compared with 2020\u20132022). In 2026, the lowest predicted male rate is expected in the Philippines (72.1 per 100\u2005000), and the highest one in Australia (92.3 per 100\u2005000). Among females, the lowest predicted ASR (42.2 per 100\u2005000) is in the Republic of Korea, whereas the highest one (74.1 per 100\u2005000) in the Philippines. Trends are generally favourable for lung, stomach, colorectum, and other major neoplasms considered, except pancreas. Predicted prostate cancer mortality is favourable in all countries and across all age groups. Rates are expected to remain low in Hong Kong SAR, Japan, and the Republic of Korea, with ASRs below 4 per 100\u2005000 males. Since the 1993 observed peak rate, an estimated 132\u2005000 total cancer deaths were avoided in Hong Kong SAR, 75\u2005000 in Israel, 1\u2005366\u2005000 in Japan, 720\u2005000 in the Republic of Korea, 328\u2005000 in Australia, and 102\u2005000 among men in the Philippines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Declining cancer mortality is predicted in the countries considered. These trends largely reflect smoking cessation along with improvements in prevention, early detection, and treatment. However, substantial geographic disparities persist, highlighting the need for strengthened cancer control strategies, particularly in ageing populations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/cej.0000000000001013","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T09:00:10Z","timestamp":1774256410000},"page":"557-569","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Cancer mortality predictions for 2026 in selected Asian countries and Australia with focus on prostate cancer"],"prefix":"10.1097","volume":"35","author":[{"given":"Claudia","family":"Santucci","sequence":"first","affiliation":[{"name":"Department of Clinical Sciences and Community Health, University of Milan"},{"name":"Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Mignozzi","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences and Community Health, University of Milan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Levi","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Health Services Research, Centre for Primary Care and Public Health (Unisant\u00e9), University of Lausanne, Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Malvezzi","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, University of Parma, Parma"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Corso","sequence":"additional","affiliation":[{"name":"Division of Breast Surgery, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS)"},{"name":"Department of Oncology and Hemato-Oncology, University of Milan, Milan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Negri","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences, University of Bologna, Bologna"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Gandaglia","sequence":"additional","affiliation":[{"name":"Department of Urology, Unit of Urology\/Division of Oncology, Gianfranco Soldera Prostate Cancer Lab, Urological Research Institute (URI), IRCCS San Raffaele Scientific Institute, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"La Vecchia","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences and Community Health, University of Milan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"key":"R3-20261118","doi-asserted-by":"crossref","first-page":"1144012","DOI":"10.3389\/fpubh.2023.1144012","article-title":"Magnitude and determinants of alcohol use disorder among adult population in East Asian countries: a systematic review and meta-analysis.","volume":"11","author":"Belay","year":"2023","journal-title":"Front Public Health"},{"key":"R4-20261118","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.jtho.2023.05.024","article-title":"Air pollution and lung cancer: a review by International Association for the study of lung cancer early detection and screening committee.","volume":"18","author":"Berg","year":"2023","journal-title":"J Thorac Oncol"},{"key":"R5-20261118","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.eururo.2023.04.021","article-title":"2022 Update on prostate cancer epidemiology and risk factors-a systematic review.","volume":"84","author":"Bergengren","year":"2023","journal-title":"Eur Urol"},{"key":"R6-20261118","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1016\/S0140-6736(24)00550-6","article-title":"Global fertility in 204 countries and territories, 1950\u20132021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021.","volume":"403","author":"Bhattacharjee","year":"2024","journal-title":"Lancet"},{"key":"R7-20261118","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.3390\/vaccines12111293","article-title":"Human Papillomavirus (HPV) vaccination: progress, challenges, and future directions in global immunization strategies.","volume":"12","author":"Branda","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"R8-20261118","doi-asserted-by":"crossref","first-page":"488","DOI":"10.20892\/j.issn.2095-3941.2024.0561","article-title":"National prevention programs and their effects on gastric cancer Incidence and mortality in East Asian countries.","volume":"22","author":"Cai","year":"2025","journal-title":"Cancer Biol Med"},{"key":"R9-20261118","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/annonc\/mdy489","article-title":"Cancer mortality and predictions for 2018 in selected Australasian countries and Russia.","volume":"30","author":"Carioli","year":"2019","journal-title":"Ann Oncol"},{"key":"R10-20261118","doi-asserted-by":"crossref","first-page":"1219827","DOI":"10.3389\/fendo.2023.1219827","article-title":"Metabolic syndrome and risk of ovarian cancer: a systematic review and meta-analysis.","volume":"14","author":"Chen","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R11-20261118","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/S2468-1253(19)30347-4","article-title":"The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017.","volume":"4","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R12-20261118","doi-asserted-by":"crossref","first-page":"e729","DOI":"10.1016\/S2468-2667(24)00166-X","article-title":"Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021.","volume":"9","year":"2024","journal-title":"Lancet Public Health"},{"key":"R13-20261118","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1470-2045(25)00017-8","article-title":"Cancer incidence and mortality estimates in 2022 in Southeast Asia: a comparative analysis.","volume":"26","author":"Dee","year":"2025","journal-title":"Lancet Oncol"},{"key":"R15-20261118","article-title":"Bladder cancer incidence and mortality: a global overview and recent trends.","author":"Filho","year":"2025","journal-title":"Eur Urol"},{"key":"R16-20261118","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/jgh.16910","article-title":"Incidence and mortality of colorectal cancer in Asia in 2022 and projections for 2050.","volume":"40","author":"Fu","year":"2025","journal-title":"J Gastroenterol Hepatol"},{"key":"R17-20261118","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/ijc.24769","article-title":"Risk factors for breast cancer among Filipino women in Manila.","volume":"126","author":"Gibson","year":"2010","journal-title":"Int J Cancer"},{"key":"R19-20261118","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1016\/S0140-6736(15)61152-7","article-title":"HPV vaccination crisis in Japan.","volume":"385","author":"Hanley","year":"2015","journal-title":"Lancet"},{"key":"R21-20261118","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s12957-015-0648-9","article-title":"Phytoestrogens and risk of prostate cancer: a meta-analysis of observational studies.","volume":"13","author":"He","year":"2015","journal-title":"World J Surg Oncol"},{"key":"R22-20261118","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1186\/s12889-024-17875-6","article-title":"Global burden of pancreatic cancer attributable to metabolic risks from 1990 to 2019, with projections of mortality to 2030.","volume":"24","author":"He","year":"2024","journal-title":"BMC Public Health"},{"key":"R23-20261118","doi-asserted-by":"crossref","first-page":"101936","DOI":"10.1016\/j.pmedr.2022.101936","article-title":"Breast and cervical cancer screening in the Philippines: challenges and steps forward.","volume":"29","author":"Ho","year":"2022","journal-title":"Prev Med Rep"},{"key":"R24-20261118","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1111\/bju.16900","article-title":"Global viewpoints: evolving epidemiology and treatment patterns of prostate cancer in Asia.","volume":"136","author":"Ito","year":"2025","journal-title":"BJU Int"},{"key":"R25-20261118","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1002\/ijc.29408","article-title":"The high prevalence of undiagnosed prostate cancer at autopsy: implications for epidemiology and treatment of prostate cancer in the Prostate-specific Antigen-era.","volume":"137","author":"Jahn","year":"2015","journal-title":"Int J Cancer"},{"key":"R26-20261118","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/S0140-6736(24)00651-2","article-title":"The Lancet Commission on prostate cancer: planning for the surge in cases.","volume":"403","author":"James","year":"2024","journal-title":"Lancet"},{"key":"R27-20261118","doi-asserted-by":"crossref","first-page":"e2400054","DOI":"10.1200\/GO.24.00054","article-title":"Trends in presentation, management, and survival of women with breast cancer in a multiethnic, middle-income Asian setting.","volume":"10","author":"Jaya-Prakason","year":"2024","journal-title":"JCO Glob Oncol"},{"key":"R28-20261118","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.eururo.2023.03.029","article-title":"Epidemiology of bladder cancer in 2023: a systematic review of risk factors.","volume":"84","author":"Jubber","year":"2023","journal-title":"Eur Urol"},{"key":"R29-20261118","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","article-title":"Permutation tests for joinpoint regression with applications to cancer rates.","volume":"19","author":"Kim","year":"2000","journal-title":"Stat Med"},{"key":"R30-20261118","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.3390\/cancers17061013","article-title":"Rising trends in prostate cancer among Asian men: global concerns and diagnostic solutions.","volume":"17","author":"Ko","year":"2025","journal-title":"Cancers (Basel)"},{"key":"R31-20261118","doi-asserted-by":"crossref","first-page":"e70148","DOI":"10.1002\/deo2.70148","article-title":"Current status of gastric cancer screening and future perspectives.","volume":"6","author":"Kusano","year":"2026","journal-title":"DEN Open"},{"key":"R32-20261118","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/CEJ.0000000000000217","article-title":"Ovarian cancer: epidemiology and risk factors.","volume":"26","author":"La Vecchia","year":"2017","journal-title":"Eur J Cancer Prev"},{"key":"R33-20261118","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/s12957-025-03937-5","article-title":"Global, regional, and national burden and trends of prostate cancer in elderly from 1990 to 2021: results from global burden of disease 2021.","volume":"23","author":"Li","year":"2025","journal-title":"World J Surg Oncol"},{"key":"R34-20261118","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s12325-022-02302-2","article-title":"Real-world study of regional differences in patient demographics, clinical characteristics, and BRCA1\/2 mutation testing in patients with human epidermal growth factor receptor 2-negative advanced breast cancer in the United States, Europe, and Israel.","volume":"40","author":"Mahtani","year":"2023","journal-title":"Adv Ther"},{"key":"R35-20261118","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/CCO.0b013e32835eb5d1","article-title":"Biological determinants of health disparities in prostate cancer.","volume":"25","author":"Martin","year":"2013","journal-title":"Curr Opin Oncol"},{"key":"R36-20261118","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/CEJ.0000000000000959","article-title":"Cancer mortality predictions for 2025 in Latin America with focus on prostate cancer.","volume":"35","author":"Mignozzi","year":"2026","journal-title":"Eur J Cancer Prev"},{"key":"R37-20261118","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/jfcm.jfcm_211_24","article-title":"Awareness of prostate cancer and its screening tests in men in the Middle East: a systematic review and meta-analysis.","volume":"32","author":"Mohamed","year":"2025","journal-title":"J Family Community Med"},{"key":"R38-20261118","first-page":"779","article-title":"Salt intake and gastric cancer: a pooled analysis within the Stomach cancer Pooling (StoP) Project.","volume":"33","author":"Morais","year":"2022","journal-title":"Cancer Causes Control"},{"key":"R39-20261118","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(15)00130-0","article-title":"Endometrial cancer.","volume":"387","author":"Morice","year":"2016","journal-title":"Lancet"},{"key":"R41-20261118","doi-asserted-by":"crossref","first-page":"ix117","DOI":"10.1093\/annonc\/mdy441.017","article-title":"Incidence of germline BRCA1 and BRCA2 mutations among Filipinos.","volume":"29","author":"Que","year":"2018","journal-title":"Ann Oncol"},{"key":"R42-20261118","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/CEJ.0000000000000889","article-title":"Cancer mortality predictions for 2024 in selected Asian countries and Australia with focus on stomach cancer.","volume":"33","author":"Santucci","year":"2024","journal-title":"Eur J Cancer Prev"},{"key":"R43-20261118","doi-asserted-by":"crossref","DOI":"10.1016\/j.annonc.2025.12.005","article-title":"European cancer mortality predictions for the year 2026: the levelling of female lung cancer mortality.","author":"Santucci","year":"2026","journal-title":"Ann Oncol"},{"key":"R44-20261118","first-page":"144","article-title":"Genetics of prostate cancer.","volume":"23","author":"Shevach","year":"2025","journal-title":"Clin Adv Hematol Oncol"},{"key":"R45-20261118","first-page":"e70043","article-title":"Cancer statistics, 2026.","volume":"76","author":"Siegel","year":"2026","journal-title":"CA Cancer J Clin"},{"key":"R46-20261118","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1053\/j.gastro.2023.11.286","article-title":"The effect of nationwide organized cancer screening programs on gastric cancer mortality: a synthetic control study.","volume":"166","author":"Sun","year":"2024","journal-title":"Gastroenterology"},{"key":"R48-20261118","article-title":"Overcoming barriers to prostate cancer care in the Philippines.","volume":"3","author":"Vergara","year":"2023","journal-title":"Front Urol"},{"key":"R49-20261118","doi-asserted-by":"crossref","first-page":"102983","DOI":"10.1016\/j.eclinm.2024.102983","article-title":"Worldwide patterns and trends in ovarian cancer incidence by histological subtype: a population-based analysis from 1988 to 2017.","volume":"79","author":"Wei","year":"2025","journal-title":"eClinicalMedicine"},{"key":"R52-20261118","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1038\/s41375-025-02598-3","article-title":"National cancer system metrics and leukemia outcomes: an analysis of global data for pediatric and adult patients.","volume":"39","author":"Wu","year":"2025","journal-title":"Leukemia"},{"key":"R53-20261118","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3390\/curroncol32060298","article-title":"The burden and trends of gynecological cancers in Asia from 1980 to 2021, with projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021.","volume":"32","author":"Yang","year":"2025","journal-title":"Curr Oncol"},{"key":"R54-20261118","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.3332\/ecancer.2023.1639","article-title":"Young Filipino breast cancer patients have worse survival outcomes.","volume":"17","author":"Yap","year":"2023","journal-title":"Ecancermedicalscience"},{"key":"R55-20261118","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.contraception.2016.02.006","article-title":"Contraception in Japan: current trends.","volume":"93","author":"Yoshida","year":"2016","journal-title":"Contraception"}],"container-title":["European Journal of Cancer Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CEJ.0000000000001013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T14:00:51Z","timestamp":1795010451000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/CEJ.0000000000001013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/cej.0000000000001013","relation":{},"ISSN":["0959-8278","1473-5709"],"issn-type":[{"value":"0959-8278","type":"print"},{"value":"1473-5709","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,23]]}}}